✦ LIBER ✦

499 VERY-EARLY VIRAL RESPONSE (WEEK-1) TO TRIPLE THERAPY WITH TELAPREVIR, PEG-INTERFERON AND RIBAVIRIN PREDICTS EXTENDED-RVR AND TREATMENT OUTCOMES IN PATIENTS WITH HCV GENOTYPE 1

✍ Scribed by Takaguchi, K.; Toyota, H.; Seno, T.; Baba, N.; Nagano, T.; Kumada, T.; Kato, K.; Shimada, N.; Ide, T.; Sata, M.; Tsubota, A.; Izumi, N.

Book ID: 122925527
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 66 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60501-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An early viral response to standard inte

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract As combination therapy with peginterferon (PEG‐IFN) and ribavirin has a high morbidity, identifying individuals with hepatitis C virus (HCV) who will not respond to the treatment would be beneficial. The early responses of serum HCV RNA levels to standard interferon (IFN) and PEG‐IFN we

Using early viral kinetics to predict an

Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1

✍ Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 657 KB

IL28B But Not ITPA Polymorphism Is Predi

IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

✍ Kamatani, N.; Sezaki, H.; Chayama, K.; Hayes, C. N.; Abe, H.; Miki, D.; Ochi, H. 📂 Article 📅 2011 🏛 University of Chicago Press 🌐 English ⚖ 454 KB

Baseline factors and very early viral re

Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study

✍ Shimada, Noritomo; Toyoda, Hidenori; Tsubota, Akihito; Ide, Tatsuya; Takaguchi, 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 295 KB

Response to peginterferon plus ribavirin

Response to peginterferon plus ribavirin and subsequent retreatment with telaprevir-based triple therapy in a patient with chronic lymphocytic leukaemia and chronic HCV genotype 1b infection

✍ Christensen, Stefan; Gillessen, Anton 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 143 KB

730 Early viral response to CPG 10101, i

730 Early viral response to CPG 10101, in combination with pegylated interferon and/or ribavirin, in chronic HCV genotype 1 infected patients with prior relapse response

✍ J.G. McHutchison; R. Chalib; E. Tawitz; P. Kwo; B. Freilich; A. Muir; E. Masciar 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB